She is left alone to do the clinical and financial side? What the hell is Hopper doing?
CDH 17, finally we know what's critical, 6 patients needed. After that, no money for ph2 - unless RM can activate her contacts. Death or Live, decision by March.
CLTX suddenly a burden.
Now depending on the NK - trial partners MD and CW to do the heavy lifting.
Clinical is the HERO, financial is ZERO.
That's a huge risk.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.323M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $26.66K | 8.722M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 71177716 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 94220096 | 28 |
View Market Depth
| Last trade - 14.10pm 28/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |